Gerwin Heller

3.6k total citations
77 papers, 2.0k citations indexed

About

Gerwin Heller is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Gerwin Heller has authored 77 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 32 papers in Oncology and 16 papers in Immunology. Recurrent topics in Gerwin Heller's work include Epigenetics and DNA Methylation (20 papers), Cancer Immunotherapy and Biomarkers (13 papers) and Acute Myeloid Leukemia Research (12 papers). Gerwin Heller is often cited by papers focused on Epigenetics and DNA Methylation (20 papers), Cancer Immunotherapy and Biomarkers (13 papers) and Acute Myeloid Leukemia Research (12 papers). Gerwin Heller collaborates with scholars based in Austria, Germany and United States. Gerwin Heller's co-authors include Sabine Zöchbauer‐Müller, Christoph Zielinski, Barbara Ziegler, Leonhard Müllauer, Veronika Sexl, Erwin Tomasich, György Láng, Adelheid End‐Pfützenreuter, Karoline Kollmann and Matthias Preusser and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Gerwin Heller

74 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gerwin Heller Austria 25 1.2k 583 485 333 308 77 2.0k
David Y. Chen United States 21 1.8k 1.4× 908 1.6× 458 0.9× 216 0.6× 278 0.9× 62 2.7k
Trisha M. Wise‐Draper United States 30 1.2k 1.0× 1.2k 2.1× 437 0.9× 378 1.1× 418 1.4× 140 2.5k
Christopher C. Porter United States 24 984 0.8× 497 0.9× 205 0.4× 286 0.9× 158 0.5× 83 1.8k
Silvia Monestiroli Italy 12 1.3k 1.0× 726 1.2× 402 0.8× 292 0.9× 148 0.5× 13 1.8k
Bin Shi China 10 1.2k 0.9× 852 1.5× 606 1.2× 219 0.7× 271 0.9× 16 2.1k
Mei Dong China 18 1.2k 1.0× 539 0.9× 332 0.7× 119 0.4× 159 0.5× 36 1.7k
Raushan T. Kurmasheva United States 27 1.3k 1.1× 814 1.4× 366 0.8× 118 0.4× 546 1.8× 120 2.3k
María J. Pajares Spain 31 1.4k 1.1× 725 1.2× 621 1.3× 681 2.0× 661 2.1× 60 2.7k
Oliver Bechter Belgium 24 767 0.6× 603 1.0× 198 0.4× 238 0.7× 214 0.7× 95 1.7k
Ryo Tamura Japan 22 859 0.7× 240 0.4× 414 0.9× 385 1.2× 162 0.5× 67 2.1k

Countries citing papers authored by Gerwin Heller

Since Specialization
Citations

This map shows the geographic impact of Gerwin Heller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerwin Heller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerwin Heller more than expected).

Fields of papers citing papers by Gerwin Heller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerwin Heller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerwin Heller. The network helps show where Gerwin Heller may publish in the future.

Co-authorship network of co-authors of Gerwin Heller

This figure shows the co-authorship network connecting the top 25 collaborators of Gerwin Heller. A scholar is included among the top collaborators of Gerwin Heller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerwin Heller. Gerwin Heller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Çifçi, Didem, Erwin Tomasich, Maximilian J. Mair, et al.. (2025). Density and entropy of immune cells within the tumor microenvironment of primary tumors and matched brain metastases. Acta Neuropathologica Communications. 13(1). 34–34. 1 indexed citations
2.
Klampfl, Thorsten, Eszter Doma, Omar Torres‐Quesada, et al.. (2025). CDK6 kinase inhibition unmasks metabolic dependencies in BCR::ABL1+ leukemia. Cell Death and Disease. 16(1). 107–107. 2 indexed citations
3.
Trifinopoulos, Jana, Thorsten Klampfl, Klara R. Klein, et al.. (2024). Cyclin C promotes development and progression of B-cell acute lymphoblastic leukemia by counteracting p53-mediated stress responses. Haematologica. 110(4). 877–892.
4.
Tomasich, Erwin, Jakob Mühlbacher, Katharina Wöran, et al.. (2024). Immune cell distribution and DNA methylation signatures differ between tumor and stroma enriched compartment in pancreatic ductal adenocarcinoma. Translational research. 271. 40–51. 2 indexed citations
5.
Doma, Eszter, Thorsten Klampfl, Michaela Prchal‐Murphy, et al.. (2024). Kinase-inactivated CDK6 preserves the long-term functionality of adult hematopoietic stem cells. Blood. 144(2). 156–170. 5 indexed citations
6.
7.
Berger, J.M., Erwin Tomasich, M. Korpan, et al.. (2024). 23P Non-small cell lung cancer DNA methylation profiles correlate with immune checkpoint inhibitor response. Immuno-Oncology Technology. 24. 100905–100905. 1 indexed citations
8.
Tomasich, Erwin, Helmut Ringl, Gerwin Heller, et al.. (2023). Correlation of DNA methylation signatures with response to immune checkpoint inhibitors in metastatic melanoma.. Journal of Clinical Oncology. 41(16_suppl). 9561–9561. 1 indexed citations
9.
Tomasich, Erwin, Ariane Steindl, Rainer Puhr, et al.. (2023). Frequent Overexpression of HER3 in Brain Metastases from Breast and Lung Cancer. Clinical Cancer Research. 29(16). 3225–3236. 14 indexed citations
10.
Karonitsch, Thomas, Victoria Saferding, Markus Kieler, et al.. (2023). Amino Acids Fueling Fibroblast‐Like Synoviocyte Activation and Arthritis By Regulating Chemokine Expression and Leukocyte Migration. Arthritis & Rheumatology. 76(4). 531–540. 3 indexed citations
11.
Pichler, Alexander, Christoph Kornauth, Lukas Kazianka, et al.. (2023). Distinct Subtypes of Chemotherapy-Resistant Systemic ALK-Positive Anaplastic Large Cell Lymphoma Demonstrate Long-Term Complete Remissions to Imatinib. Blood. 142(Supplement 1). 1691–1691. 1 indexed citations
12.
Mair, Maximilian J., Gerwin Heller, Rainer Puhr, et al.. (2022). Early Postoperative Treatment versus Initial Observation in CNS WHO Grade 2 and 3 Oligodendroglioma: Clinical Outcomes and DNA Methylation Patterns. Clinical Cancer Research. 28(20). 4565–4573. 8 indexed citations
13.
Nguyen, Chi Huu, Hubert Hackl, Heinz Sill, et al.. (2021). Downregulation of MTSS1 in acute myeloid leukemia is associated with a poor prognosis, chemotherapy resistance, and disease aggressiveness. Leukemia. 35(10). 2827–2839. 13 indexed citations
14.
Saferding, Victoria, Melanie Hofmann, Julia S. Brunner, et al.. (2020). microRNA‐146a controls age‐related bone loss. Aging Cell. 19(11). e13244–e13244. 28 indexed citations
15.
Nguyen, Chi Huu, Elisabeth Koller, Emiel van der Kouwe, et al.. (2020). IL2RA Promotes Aggressiveness and Stem Cell–Related Properties of Acute Myeloid Leukemia. Cancer Research. 80(20). 4527–4539. 23 indexed citations
16.
Thallinger, Christiane, Thorsten Füreder, Matthias Preusser, et al.. (2017). Review of cancer treatment with immune checkpoint inhibitors. Wiener klinische Wochenschrift. 130(3-4). 85–91. 100 indexed citations
17.
Gotthardt, Dagmar, Eva Maria Putz, Eva Grundschober, et al.. (2016). STAT5 Is a Key Regulator in NK Cells and Acts as a Molecular Switch from Tumor Surveillance to Tumor Promotion. Cancer Discovery. 6(4). 414–429. 123 indexed citations
18.
Marhold, Maximilian, Erwin Tomasich, Ahmed El‐Gazzar, et al.. (2014). HIF1α Regulates mTOR Signaling and Viability of Prostate Cancer Stem Cells. Molecular Cancer Research. 13(3). 556–564. 72 indexed citations
19.
Heller, Gerwin, Valerie Babinsky, Barbara Ziegler, et al.. (2012). Genome-Wide miRNA Expression Profiling Identifies miR - 9 - 3 and miR - 193a as Targets for DNA Methylation in Non–Small Cell Lung Cancers. Clinical Cancer Research. 18(6). 1619–1629. 128 indexed citations
20.
Heller, Gerwin, Wolfgang M. Schmidt, Barbara Ziegler, et al.. (2008). Genome-Wide Transcriptional Response to 5-Aza-2′-Deoxycytidine and Trichostatin A in Multiple Myeloma Cells. Cancer Research. 68(1). 44–54. 132 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David Y. Chen Breakdown of academic impact, for papers by Trisha M. Wise‐Draper Breakdown of academic impact, for papers by Christopher C. Porter Breakdown of academic impact, for papers by Silvia Monestiroli Breakdown of academic impact, for papers by Bin Shi Breakdown of academic impact, for papers by Mei Dong Breakdown of academic impact, for papers by Raushan T. Kurmasheva Breakdown of academic impact, for papers by María J. Pajares Breakdown of academic impact, for papers by Oliver Bechter Breakdown of academic impact, for papers by Ryo Tamura
Rankless by CCL
2026